Correction to: Cell Death and Disease https://doi.org/10.1038/s41419-018-0574-1, published online 10 May 2018
Upon a thorough review of the published content, we recently identified mistakes in Fig. 2C and Fig. 4G due to oversights during the figure preparation process.
Specifically, we mistakenly used the same β-actin WB band, resulting in the duplication of the two bands in Fig. 1E and Fig. 2C. Additionally, the WB bands for ERK1/2 and p-ERK1/2 were mistakenly placed, resulting in inadvertent duplication of the Ras WB band in Fig. 4G.
Amended Figure 2
Original Figure 2
Amended Figure 4
Original Figure 4
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Li, Y., Xi, Z., Chen, X. et al. Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways. Cell Death Dis 16, 338 (2025). https://doi.org/10.1038/s41419-025-07495-2
Published:
DOI: https://doi.org/10.1038/s41419-025-07495-2
